FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

712714000: Gadoterate meglumine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3083348017 Gadoterate meglumine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3083501015 Gadoterate meglumine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
813941000172119 méglumine de gadotérate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gadoterate meglumine Is a Magnetic resonance imaging contrast media (substance) false Inferred relationship Some
Gadoterate meglumine Is a Gadolinium AND/OR gadolinium compound false Inferred relationship Some
Gadoterate meglumine Is a Gadolinium compound true Inferred relationship Some
Gadoterate meglumine This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Gadoteric acid (substance) true Inferred relationship Some
Gadoterate meglumine Is a Paramagnetic contrast media (substance) true Inferred relationship Some
Gadoterate meglumine Is a Gadolinium-based contrast media (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
produit contenant de la méglumine de gadotérate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gadoterate meglumine Inferred relationship Some 1
Product containing gadoterate meglumine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gadoterate meglumine Inferred relationship Some 1
Product containing only gadoterate meglumine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gadoterate meglumine Inferred relationship Some 1
Product containing only gadoterate meglumine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gadoterate meglumine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start